Biotech Values

[DewDiligence]

Re: ADH ACTC

>While Dew was away, ADH spiked higher on no news that I could find.<

I’ve posted ad nauseam that the day to day price swings of ADH are all but meaningless. We didn’t take a computer on our trip to Vermont, so I didn’t know about last week’s spike until yesterday. It wouldn’t have made any difference, anyhow, because I’m certainly not selling any at these prices.

>ACTC exploded (giving much of back) on "groundbreaking" news of using embryonic stem cells without destroying the embryo… I'm curious to know if ACTC is for real (I currently have no position, but find the company's technology intriguing).<

The ACTC news from last week is probably not going to be consequential from a business standpoint, IMO. There are still many ethical issues associated with what ACT is claiming to be able to do, and hence I don’t see any push to make it some kind of standardized process that could sustain an IP-oriented business model. Regards, Dew